Aphrodine Hydrochloride,
Aphrodyne,
Corynanthine,
Corynanthine Tartrate,
Hydrochloride, Aphrodine,
Hydrochloride, Yohimbine,
Pluriviron,
Rauhimbine,
Rauwolscine,
Tartrate, Corynanthine,
Yocon,
Yohimbin Spiegel,
Yohimbine,
Yohimbine Houdé,
Yohimbine Hydrochloride,
Yohimex,
YOHIMBINE HYDROCHLORIDE,
65-19-0,
Antagonil,
Yohimbine HCl,
Yohimbe,
Aphrodine hydrochloride,
Yohimbine monohydrochloride,
Yohimbine (Hydrochloride),
UNII-NB2E1YP49F,
Yohimbin hydrochloride [USP],
EINECS 200-600-4,
NSC 19509,
NB2E1YP49F,
C21H26N2O3.HCl,
AI3-60247,
Aphrodyne,
Thybine,
AK208923,
17-Hydroxyyohimban-16-carboxylic acid methyl ester hydrochloride,
Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, monohydrochloride, (16alpha,17alpha)-,
Yohimbine hydrochloride, 99%,
YOHIMBINE CHLORIDE,
Yohimbin HCl,
CHEMBL537669,
17alpha-Hydroxy-20-alpha-yohimban-16-beta-carboxylic acid, methyl ester, hydrochloride,
Yohimban-16-alpha-carboxylic acid, 17-alpha-hydroxy-, methyl ester, hydrochloride,
SMR000058527,
Yohimbin hydrochloride,
SR-01000597896,
Dayto-Himbin,
SR-01000075297,
MFCD00012674,
Yohimbine Extract,
Yohimbine, HCl,
65-19-0(hcl),
Yohimbine hydrochloride [USP:BAN],
methyl (1S,15R,18S,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate;hydrochloride,
Prestwick_961,
NSC19509,
Yohimbine-Hydrochloride,
AC1L1LXU,
AC1Q3E9L,
MLS001306411,
MLS001333983,
Yohimbine hydrochloride (USP),
Yohimbine-hydrochloride(Antagonil),
HMS1569F10,
Yohimbine hydrochloride (Antagonil),
(1R,2S,4aR,13bS,14aS)-methyl 2-hydroxy-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydroindolo[2',3':3,4]pyrido[1,2-b]isoquinoline-1-carboxylate hydrochloride,
ACN-S004280,
BCP19708,
HY-N0127,
NIH 9689,
Tox21_501210,
CY0011,
s2373,
AKOS015951349,
API0004633,
CCG-208327,
CS-5238,
LP01210,
MCULE-4460720994,
NCGC00094457-01,
NCGC00261895-01,
AC-22571,
AS-13939,
AB1009559,
LS-162742,
Yohimbine hydrochloride, analytical standard,
EU-0101210,
N1704,
SW199050-2,
D06671,
Y 3125,
Yohimbine hydrochloride, >=98% (TLC), powder,
012Y674,
Q-201938,
SR-01000075297-1,
SR-01000597896-1,
SR-01000597896-4,
Yohimbine hydrochloride, European Pharmacopoeia (EP) Reference Standard,
Yohimbine hydrochloride, United States Pharmacopeia (USP) Reference Standard,
Antagonil, Yohimbe, Aphrodine hydrochloride, Yohimbine monohydrochloride, 65-19-0,
Yohimban-16alpha-carboxylic acid, 17alpha-hydroxy-, methyl ester, monohydrochloride,
Yohimban-16alpha-carboxylic acid, 17alpha-hydroxy-, methyl ester, monohydrochloride (8CI),
Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, hydrochloride (1:1), (16alpha,17alpha)-,
Actibine,
Erex,
Yohimbe HCl,
Yohimbinehydrochloride,
yohimbinhydrochlorid-,
DPIN,
C21H26N2O3.ClH,
CID6169,
C21-H26-N2-O3.Cl-H,
AR-1H0746,
ACN-035706,
CS-T-62809,
Yohimbine hydrochloride, 98% - 1G 1g,
N025,
65-19-0 (HCL),
Y0002,
(16,17)-17-hydroxy-Yohimban-16-carboxylic acid methyl ester hydrochloride,
6764-45-0,
Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, monohydrochloride, (16.alpha.,17.alpha.)-,